- Opportunity and Forecast, 2016-2025
X-ray detector is a device used for measuring flux, spectrum, spatial distribution, and other properties of x-rays. There are two types of detectors, namely imaging detectors and dose measurement detectors. In imaging detectors, the body part of the patient to be x-rayed is placed between x-ray source and image receptor to obtain a shadow. Dose measurement detectors are two types, namely gas detectors and silicon PN solar cells. High speed and high resolution detection, lightweight, and low noise are some of the benefits offered by technologically advanced detectors.
The global x-ray detector market is driven by growth in government investments, increase in geriatric population, high prevalence of chronic diseases, and rise in demand for photographic films. However, stringent regulatory scenario and high initial investment costs hamper the market growth. Moreover, technological advancements in the sector to improve portability & enable power saving and boom in medical tourism, especially in Asian countries, are anticipated to create lucrative opportunities in the industry.
The global x-ray detector market is segmented based on product, application, and geography. Based on product, the market is segmented into flat panel displays (FPD), line scan, computed radiography (CR), and charge couple device (CCD). The application areas of the industry are medical, industrial, security, dental, and veterinary. The market is analyzed based on four regions, namely Asia-Pacific, North America, Europe, and LAMEA.
The key players operating in the market are Varian Medical Systems, Canon Inc., PerkinElmer Inc., Thales Group, Konica Minolta Inc., Analogic Corp., Agfa-Gevaerf Group, YXLON International, Fujifilm Medical Systems, and Teledyne DALSA Inc. These market players have adopted various strategies such as new products launch, expansion, collaboration, joint ventures, partnerships, mergers & acquisitions, and other strategies to consolidate their market position and gain competitive edge in the market.
The United States Amniotic Membrane Market accounted for $189 million in 2012 and is expected to reach $722 million by 2022, registering a CAGR of 13.6% from 2017 to 2022. Read More >>